CN108671155A - 一种用于治疗癫痫的中药组合物及其制备方法 - Google Patents
一种用于治疗癫痫的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN108671155A CN108671155A CN201810821191.6A CN201810821191A CN108671155A CN 108671155 A CN108671155 A CN 108671155A CN 201810821191 A CN201810821191 A CN 201810821191A CN 108671155 A CN108671155 A CN 108671155A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- epilepsy
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010015037 epilepsy Diseases 0.000 title claims abstract description 51
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims description 16
- 241000255789 Bombyx mori Species 0.000 claims abstract description 13
- 241000522620 Scorpio Species 0.000 claims abstract description 13
- 239000009490 scorpio Substances 0.000 claims abstract description 13
- 229910052956 cinnabar Inorganic materials 0.000 claims abstract description 12
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 210000000582 semen Anatomy 0.000 claims abstract description 12
- 244000205574 Acorus calamus Species 0.000 claims abstract description 11
- 235000011996 Calamus deerratus Nutrition 0.000 claims abstract description 11
- 239000010975 amethyst Substances 0.000 claims abstract description 11
- 244000153234 Hibiscus abelmoschus Species 0.000 claims abstract description 8
- 208000001130 gallstones Diseases 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims description 39
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- 241001247821 Ziziphus Species 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 230000036461 convulsion Effects 0.000 abstract description 10
- 206010010904 Convulsion Diseases 0.000 abstract description 9
- 238000011282 treatment Methods 0.000 abstract description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 7
- 208000026435 phlegm Diseases 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000036528 appetite Effects 0.000 abstract description 4
- 235000019789 appetite Nutrition 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 4
- 239000000796 flavoring agent Substances 0.000 abstract description 4
- 208000021760 high fever Diseases 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000004936 stimulating effect Effects 0.000 abstract description 2
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 230000001037 epileptic effect Effects 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000010415 tropism Effects 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010012373 Depressed level of consciousness Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 238000007596 consolidation process Methods 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000001314 paroxysmal effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 206010004542 Bezoar Diseases 0.000 description 1
- 208000018152 Cerebral disease Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- FJPYVLNWWICYDW-UHFFFAOYSA-M sodium;5,5-diphenylimidazolidin-1-ide-2,4-dione Chemical compound [Na+].O=C1[N-]C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 FJPYVLNWWICYDW-UHFFFAOYSA-M 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种用于治疗癫痫的中药组合物,包括以下重量份数的组分:炒枣仁、制南星、法半夏、琥珀、远志、龙齿、外菖蒲、全蝎、天麻、茯神、丹参、白芍、麝香、朱砂、天然牛黄、僵蚕、大枣、紫石英、海南沉香。本发明采用多味天然纯中草药为原料,具有豁痰开窍,熄风定惊,健脾开胃和填精补髓的功效,治疗癫痫症的疗效显著、治愈率高;本发明的中药组合物与现有技术相比,具有疗程短、简单方便和无毒副作用的特点。
Description
技术领域
本发明涉及一种用于治疗癫痫的中药组合物,具体来说是涉及是一种用于治疗癫痫的中药组合物及其制备方法。
背景技术
癫痫(epilepsy)即俗称的"羊角风"或"羊癫风",是大脑神经元突发性异常放电,导致短暂的大脑功能障碍的一种慢性疾病。据中国最新流行病学资料显示,国内癫痫的总体患病率为7.0‰,年发病率为28.8/10万,1年内有发作的活动性癫痫患病率为4.6‰。据此估计中国约有900万左右的癫痫患者,其中500~600万是活动性癫痫患者,同时每年新增加癫痫患者约40万,在中国癫痫已经成为神经科仅次于头痛的第二大常见病。患此症者不能够正常工作,极容易发生意外,给家属和人带来极大的痛苦,目前市场对此无针对性治疗的中药组合物,治之不愈者终生受此症煎熬。
西医多采用苯巴比妥、苯妥英钠、卡马西平、地西泮、丙戊酸钠等药物治疗,一般只能控制或减轻其症状,而且长期使用对人的肝肾等器官有较大的损害。
因此,亟待发明一种无毒副作用的中药组合物用于此症的治疗。
发明内容
本发明的目的在于提供一种用于治疗癫痫的中药组合物及其制备方法。此中药组合物治疗癫痫病效果好,疗效显著,无毒副作用,简单方便,治疗费用低。
为了实现上述目的,本发明采取以下方案:
一种用于治疗癫痫的中药组合物,包括以下重量份数的组分:炒枣仁20-50份、制南星20-50份、法半夏10-40份、琥珀0.5-10份、远志10-40份、龙齿15-50份、外菖蒲5-30份、全蝎5-30份、天麻5-30份、茯神10-40份、丹参10-40份、白芍10-30份、朱砂3-20份、僵蚕5-25份、大枣10-40份、紫石英10-40份和海南沉香10-40份。
优选地,用于治疗痫症的中药组合物,包括以下重量份数的组分:炒枣仁25-40份、制南星25-40份、法半夏10-30份、琥珀1-5份、远志15-30份、龙齿20-40份、外菖蒲10-20份、全蝎10-20份、天麻8-20份、茯神15-30份、丹参15-30份、白芍15-25份、朱砂5-15份、僵蚕10-20份、大枣12-30份、紫石英15-30份和海南沉香12-30份。
优选地,用于治疗痫症的中药组合物还包括以下重量份数的组分:麝香2-15份、天然牛黄3-20份。
更优选地,用于治疗痫症的中药组合物,包括以下重量份数的组分:
炒枣仁30份、制南星30份、法半夏15份、琥珀1.2份、远志20份、龙齿25份、外菖蒲12份、全蝎12份、天麻10份、茯神20份、丹参20份、白芍20份、麝香6份、朱砂8份、天然牛黄6份、僵蚕12份、大枣15份、紫石英20份和海南沉香15份。
本发明的药物机理如下:
僵蚕:味咸、辛,性平。归肝、脾经。具有熄风止痉,祛风止痛,化痰散结的功效。本品可用于惊痫抽搐。本品咸、辛、平,入肝脾二经,既能熄风直痉,又能化痰定惊,故对惊风、癫痫而挟痰热者尤为适宜。
全蝎:辛,平;有毒。归肝经。用于小儿惊风,抽搐痉挛,中风口歪,半身不遂,破伤风,风湿顽痹,偏正头痛,疮疡,瘰疬。
法半夏:性味:辛、温。归经:归脾、胃、肺经。主治:用于咽喉干燥,痰多咳喘,痰饮眩悸,风痰眩晕,痰厥头痛。
远志:性味苦、辛、温。归经归心、肾、肺经。功能主治:安神益智,解郁。治惊悸,健忘,梦遗,失眠,咳嗽多痰,痈疽疮肿。
龙齿:性味:涩;甘;凉。归经:心经;肝经。主治:主惊痫;癫狂;心悸怔忡;失眠多梦;身热心烦。
一种用于治疗癫痫的中药组合物的制备方法,包括以下步骤:
1)称量药材:按照重量份数分别称取各组分药材;
2)混合:将步骤1)中的药材混合,得到混合药材;
3)粉碎:将混合药材粉碎,高压灭菌,过筛,即得用于治疗癫痫的中药组合物。
优选地,所述步骤3)中,混合是在常温进行。
优选地,所述步骤4)中,过筛时使用目数为90-120目的筛网。
优选地,所述步骤4)中,将混合药材在超微粉碎机中进行充分粉碎。
优选地,所述步骤4)中,高压灭菌是在50MPa下进行。
本发明的有益效果是:
1、本发明采用多味天然纯中草药为原料,具有豁痰开窍,熄风定惊,健脾开胃和填精补髓的功效,治疗癫痫症的疗效显著、治愈率高,本发明的中药组合物与现有技术相比,具有疗程短、简单方便和无毒副作用的特点。
2、所选材料皆为传统中药材料,廉价易得,减轻患者长期服用的费用。
3、本中药配方原料药配伍合理,相辅相成,能辩证施治。
具体实施方式
下面的实施例可以帮助本领域的技术人员更全面地理解本发明,但不仅限于此。
实施例1
一种用于治疗癫痫的中药组合物,包括以下重量份数的组分:
炒枣仁20份、制南星20份、法半夏10份、琥珀0.5份、远志10份、龙齿15份、外菖蒲5份、全蝎5份、天麻5份、茯神10份、丹参10份、白芍10份、朱砂3份、僵蚕5份、大枣10份、紫石英10份、海南沉香10份。
一种用于治疗癫痫的中药组合物的制备方法,包括以下步骤:
1)称量药材:按照重量份数分别称取各组分药材;
2)混合:将步骤1)中的药材混合,得到混合药材;
3)粉碎:将混合药材在超微粉碎机中进行充分粉碎,在50MPa下进行高压灭菌,过90目筛,即得用于治疗癫痫的中药组合物。
实施例2
一种用于治疗癫痫的中药组合物,包括以下重量份数的组分:
炒枣仁50份、制南星50份、法半夏40份、琥珀10份、远志40份、龙齿50份、外菖蒲30份、全蝎30份、天麻30份、茯神40份、丹参40份、白芍30份、朱砂20份、僵蚕25份、大枣40份、紫石英40份、海南沉香40份。
一种用于治疗癫痫的中药组合物的制备方法,包括以下步骤:
1)称量药材:按照重量份数分别称取各组分药材;
2)混合:将步骤1)中的药材混合,得到混合药材;
3)粉碎:将混合药材在超微粉碎机中进行充分粉碎,在50MPa下进行高压灭菌,过90目筛,即得用于治疗癫痫的中药组合物。
实施例3
一种用于治疗癫痫的中药组合物,包括以下重量份数的组分:
炒枣仁30份、制南星30份、法半夏15份、琥珀1.2份、远志20份、龙齿25份、外菖蒲12份、全蝎12份、天麻10份、茯神20份、丹参20份、白芍20份、麝香6份、朱砂8份、天然牛黄6份、僵蚕12份、大枣15份、紫石英20份、海南沉香15份。
一种用于治疗癫痫的中药组合物的制备方法,包括以下步骤:
1)称量药材:按照重量份数分别称取各组分药材;
2)混合:将步骤1)中的药材混合,得到混合药材;
3)粉碎:将混合药材在超微粉碎机中进行充分粉碎,在50MPa下进行高压灭菌,过120目筛,即得用于治疗癫痫的中药组合物。
实施例4
一种用于治疗癫痫的中药组合物,包括以下重量份数的组分:
炒枣仁25份、制南星25份、法半夏10份、琥珀1份、远志15份、龙齿20份、外菖蒲10份、全蝎10份、天麻8份、茯神15份、丹参15份、白芍15份、麝香5份、朱砂5份、天然牛黄10份、僵蚕10份、大枣12份、紫石英15份、海南沉香12份。
一种用于治疗癫痫的中药组合物的制备方法,包括以下步骤:
1)称量药材:按照重量份数分别称取各组分药材;
2)混合:将步骤1)中的药材混合,得到混合药材;
3)粉碎:将混合药材在超微粉碎机中进行充分粉碎,在50MPa下进行高压灭菌,过120目筛,即得用于治疗癫痫的中药组合物。
实施例5
一种用于治疗癫痫的中药组合物,包括以下重量份数的组分:
炒枣仁40份、制南星40份、法半夏30份、琥珀5份、远志30份、龙齿40份、外菖蒲20份、全蝎20份、天麻20份、茯神30份、丹参30份、白芍25份、麝香10份、朱砂15份、天然牛黄20份、僵蚕20份、大枣30份、紫石英30份、海南沉香30份。
一种用于治疗癫痫的中药组合物的制备方法,包括以下步骤:
1)称量药材:按照重量份数分别称取各组分药材;
2)混合:将步骤1)中的药材混合,得到混合药材;
3)粉碎:将混合药材在超微粉碎机中进行充分粉碎,在50MPa下进行高压灭菌,过120目筛,即得用于治疗癫痫的中药组合物。
我们经过多年实践,研制了本发明的药物,经临床应用400例患者,取得了良好的效果,现报告如下:
1.临床资料
本发明人对150例癫痫患者进行临床观察治疗,分成5组,每组30人,年龄20到80岁,病程1-20年不等。
2.治疗方法
5组患者分别口服本发明实施例1-5制备的药粉,每日三次,每次10g,饭后白开水送服,90天为一疗程,因是慢性病用药一般1-6个疗程治愈。
3.疗效判定标准
痊愈:临床症状体征消失,功能活动恢复正常。
显效:临床症状体征基本或大部分消失。
有效:临床症状明显好转。
无效:临床症状体征无改善。
4.结果
疗效 | 实施例1 | 实施例2 | 实施例3 | 实施例4 | 实施例5 |
痊愈 | 19 | 20 | 25 | 24 | 22 |
显效 | 6 | 5 | 2 | 3 | 4 |
有效 | 3 | 3 | 2 | 2 | 3 |
无效 | 2 | 2 | 1 | 1 | 1 |
治愈率% | 66.3 | 66.7 | 83.3 | 80 | 73.3 |
典型病例:
王某,男,30岁,自述12岁突然发烧,出现痴呆,神志不清,间断几天后出现全身抽动,目呆神志不清,持续一分钟左右,发作后全身无力,到当地医院作脑电图检查,诊为轻度脑电图慢波。查患者舌质淡,苔薄白,脉滑数,诊为癫痫部分发作。随后服用本发明的中药组合物,每日口服三次,每次10克,90天为一疗程,精神症状大为改善,发作次数已减至十天一次,继服用本药30天,患者已不再发作,食欲改善,睡眠正常,精神较前大为好转,基本症愈,复查脑电图已转为正常。至今未再发病,疗效巩固。
钟女士,24岁,自述15岁时突发性的不省人事,到当地医院作脑电图检查,诊为轻度脑电图慢波。随后服用本发明的中药组合物,每日口服三次,每次10克,90天疗程,患者已不再发作,食欲改善,睡眠正常,精神较前大为好转,基本症愈,复查脑电图已转为正常。至今未再发病,疗效巩固。
Claims (10)
1.一种用于治疗癫痫的中药组合物,其特征在于,包括以下重量份数的组分:炒枣仁20-50份、制南星20-50份、法半夏10-40份、琥珀0.5-10份、远志10-40份、龙齿15-50份、外菖蒲5-30份、全蝎5-30份、天麻5-30份、茯神10-40份、丹参10-40份、白芍10-30份、朱砂3-20份、僵蚕5-25份、大枣10-40份、紫石英10-40份和海南沉香10-40份。
2.根据权利要求1所述的用于治疗癫痫的中药组合物,其特征在于,包括以下重量份数的组分:炒枣仁25-40份、制南星25-40份、法半夏10-30份、琥珀1-5份、远志15-30份、龙齿20-40份、外菖蒲10-20份、全蝎10-20份、天麻8-20份、茯神15-30份、丹参15-30份、白芍15-25份、朱砂5-15份、僵蚕10-20份、大枣12-30份、紫石英15-30份和海南沉香12-30份。
3.根据权利要求1或2所述的用于治疗癫痫的中药组合物,其特征在于,还包括以下重量份数的组分:麝香2-15份、天然牛黄3-20份。
4.根据权利要求3所述的用于治疗癫痫的中药组合物,其特征在于,包括以下重量份数的组分:炒枣仁30份、制南星30份、法半夏15份、琥珀1.2份、远志20份、龙齿25份、外菖蒲12份、全蝎12份、天麻10份、茯神20份、丹参20份、白芍20份、麝香6份、朱砂8份、天然牛黄6份、僵蚕12份、大枣15份、紫石英20份和海南沉香15份。
5.根据权利要求1-4中任一项所述的用于治疗癫痫的中药组合物的制备方法,其特征在于,包括以下步骤:
1)称量药材:按照重量份数分别称取各组分药材;
2)混合:将步骤1)中的药材混合,得到混合药材;
3)粉碎:将混合药材粉碎,高压灭菌,过筛,即得用于治疗癫痫的中药组合物。
6.根据权利要求5所述的制备方法,其特征在于,所述步骤2)中,混合是在常温进行。
7.根据权利要求5所述的制备方法,其特征在于,所述步骤3)中,过筛时使用目数为90-120目的筛网。
8.根据权利要求5所述的制备方法,其特征在于,所述步骤3)中,将混合药材在超微粉碎机中进行充分粉碎。
9.根据权利要求5所述的制备方法,其特征在于,所述步骤3)中,高压灭菌是在50MPa下进行。
10.权利要求1-4中任一项所述的用于治疗痫症的中药组合物的在制备用于治疗癫痫的药物中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810821191.6A CN108671155A (zh) | 2018-07-24 | 2018-07-24 | 一种用于治疗癫痫的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810821191.6A CN108671155A (zh) | 2018-07-24 | 2018-07-24 | 一种用于治疗癫痫的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108671155A true CN108671155A (zh) | 2018-10-19 |
Family
ID=63815752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810821191.6A Pending CN108671155A (zh) | 2018-07-24 | 2018-07-24 | 一种用于治疗癫痫的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108671155A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007038610A2 (en) * | 2005-09-26 | 2007-04-05 | President & Fellows Of Harvard College | Use of natural products for treatment of neurological disorders |
CN101161280A (zh) * | 2006-10-12 | 2008-04-16 | 吴家平 | 一种治疗癫痫的药物 |
CN102018902A (zh) * | 2010-11-18 | 2011-04-20 | 重庆市南川区中药材品种培育研究所 | 治疗癫痫(肝风痰浊)的中草药 |
CN104173676A (zh) * | 2014-09-10 | 2014-12-03 | 张光民 | 治疗癫痫症的中药制剂及制备方法 |
-
2018
- 2018-07-24 CN CN201810821191.6A patent/CN108671155A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007038610A2 (en) * | 2005-09-26 | 2007-04-05 | President & Fellows Of Harvard College | Use of natural products for treatment of neurological disorders |
CN101161280A (zh) * | 2006-10-12 | 2008-04-16 | 吴家平 | 一种治疗癫痫的药物 |
CN102018902A (zh) * | 2010-11-18 | 2011-04-20 | 重庆市南川区中药材品种培育研究所 | 治疗癫痫(肝风痰浊)的中草药 |
CN104173676A (zh) * | 2014-09-10 | 2014-12-03 | 张光民 | 治疗癫痫症的中药制剂及制备方法 |
Non-Patent Citations (2)
Title |
---|
毕道才等: "定痫丸加减治疗小儿痫证", 《湖北中医杂志》 * |
祁友松等: "《中医经典方剂药学研究》", 30 April 2017, 中国中医药出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102319288B (zh) | 一种治疗家禽传染性法氏囊病的中药组合物及其制备方法 | |
CN103127467B (zh) | 一种治疗抑郁症的中药 | |
CN102727770B (zh) | 治疗猪流感的纯中药组合物及其制备方法 | |
CN102178892B (zh) | 一种治疗抑郁症的中药组合物 | |
CN103055076A (zh) | 治疗蜜蜂孢子虫病的纯中药组合物及其制备方法 | |
CN103251888A (zh) | 一种治疗抑郁症的中药组合物 | |
CN103599413B (zh) | 治疗鸡支原体病的中药组合物及其制备方法 | |
CN103566199B (zh) | 一种治疗颅脑损伤后综合症的中药制剂 | |
CN105943953A (zh) | 一种治疗糖尿病的保健品及其制备方法 | |
CN102727848B (zh) | 治疗家禽传染性法氏囊病的纯中药组合物及其制备方法 | |
CN102357148B (zh) | 一种治疗鸭疫里默氏杆菌病的纯中药组合物及其制备方法 | |
CN105878454B (zh) | 用于治疗中风偏瘫和风湿痹痛的药物组合物及其制备方法 | |
CN108671155A (zh) | 一种用于治疗癫痫的中药组合物及其制备方法 | |
CN106720717A (zh) | 一种具有生发益肾功效的保健茶 | |
CN104688999A (zh) | 一种提高免疫力的中药制剂 | |
CN104189120A (zh) | 一种用于治疗猪流行性感冒的中药组合物及其制备方法 | |
CN105079438B (zh) | 一种治疗病毒性心肌炎的药物制剂 | |
CN104288421A (zh) | 一种治疗偏头痛的中药组合物 | |
CN104352911B (zh) | 一种治疗家畜呼吸道疾病的组合物及其制备方法 | |
CN108904656A (zh) | 治疗颈椎病或腰椎病的药物组合物及其制备方法和用途 | |
CN107929644A (zh) | 一种治疗窦性心动过缓的中药组合物及其制备方法 | |
CN104784567B (zh) | 一种治疗泌尿系感染的药物组合物 | |
CN112972631B (zh) | 具有改善胃健康、调节肠道菌群功能的中药组合物及其制备方法 | |
CN114617939B (zh) | 一种用于治疗缺血性脑卒中的中药制剂 | |
CN102670804A (zh) | 一种治疗家禽痢疾的复方蜂胶组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181019 |